Truist Securities reiterated coverage on SeaSpine Holdings with a new price target
$SPNE
Medical Specialities
Health Care
Truist Securities reiterated coverage of SeaSpine Holdings with a rating of Buy and set a new price target of $20.00 from $25.00 previously